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include poor visibility of the small bowel on the CBCTs, 
smaller field of view meaning less volume and variation 
between initial planning clinician and clinician outlining 
CBCTs. CBCT is now widely used for adaptive planning 
techniques and in this case has provided evidence for 
implementing a stricter bladder filling protocol to improve 
the accuracy of bowel dose statistics at planning. 
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Purpose or Objective: We report the results of our 
investigation into whole brain radiotherapy using linear 
accelerator-based intensity-modulated radiation therapy and 
volumetric-modulated arc therapy in cancer patients with a 
high risk of metastasis to the brain. Concretely, we assessed 
the absorbed dose and the rate of adverse effects for several 
organs at risk according to the tilt of a patient’s head. 
 
Material and Methods: From data regarding patients who had 
previously received WBRT, we arbitrarily selected five cases 
where measurements were made with the patients’ heads 
tilted forward and five cases without such tilt. We set the 
entire brain as the planning target volume, and the 
hippocampi, the lenses, the eyes, and the cochleae as the 
main OAR, and formulated new plans for IMRT (coplanar, 
non-coplanar) and VMAT (coplanar, non-coplanar). Using the 
dose-volume histogram obtained from the treatment plans, 
we calculated and compared the effective uniform dose and 
normal tissue complication probability of the OAR. In order to 
compare the extent of hippocampal sparing, we also 
analyzed the mean and the maximum doses. 
 
 
Results: When a patient received coplanar IMRT with the 
head tilted forward, the EUD and NTCP values for the 
hippocampus decreased by 13% and 81%, and the mean dose 
and maximum dose decreased by 8% and 7%, respectively. 
When the patient received non-coplanar treatment, the 
hippocampal EUD and NTCP values decreased by 2% and 15%, 
and the mean dose and maximum dose decreased by 2% and 
4%, respectively. For coplanar VMAT treatment, the EUD 
values decreased by 20%, the NTCP values decreased by 92%, 
and the mean dose and the maximum dose decreased by 10% 
and 13%, respectively. For non-coplanar treatment as well, 
the EUD values decreased by 14%, the NTCP values decreased 
by 81%, and the mean dose and the maximum dose decreased 
by 14% and 10%. 
 
 
Conclusion: If the patient tilted the head forward when 
receiving the Linac-based treatment, for the same treatment 
effect in the PTV, we confirmed that a lower dose entered 
the OAR, such as the hippocampus, eye, lens, and cochlea. 
Also, the damage to the hippocampus was expected to be the 
least when receiving coplanar VMAT with the head tilted 
forward, and we showed that damage to OAR, including the 
hippocampus, was the least overall when the head was tilted 
forward. Accordingly, if patients tilt their heads forward 
when undergoing Linac-based WBRT, we anticipate that a 
smaller dose would be transmitted to the OAR, resulting in 
better quality of life following treatment. 
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Purpose or Objective: Postoperative radiotherapy (PORT) of 
tongue cancer is associated with side-effects such as acute 
mucositis. Our department previously used intraoral stents to 
depress the tongue to minimize the dose to the palate. 
However, the stents were not always very well tolerated and 
there were also reproducibility issues. Therefore, the 
intraoral stents were omitted. In order to still ensure target 
coverage, we have included the air gap (if present) above the 
tongue in the target volume (CTV tongue including the 
surgical bed) on the planning CT. We wanted to investigate 
whether the air gap is a systematic phenomenon over all 
treatment fractions, so that the size of the CTV could be 
reduced avoiding irradiating the palate. 
 
Material and Methods: We have so far included 10 patients 
with T1-T2 N0 M0 squamous cell carcinoma of the tongue 
referred to PORT. Nine patients were treated with 50 Gy in 2 
Gy fractions, and one patients with 60 Gy in 2 Gy fractions 
with concurrent chemotherapy (cisplatinum) because of 
positive surgical margins. All patients underwent daily kV 
cone-beam CT (CBCT). From each CBCT we obtained three 
distance measures from the sagittal images: The caudo-
cranial air gap from the cranial border of the tongue to the 
palate on the 1) lateral left, 2) midline and 3) lateral right 
side. 
 
Results: Two of 10 patients had air gaps between the tongue 
and palate systematically present over the treatment period 
(Figure, mean air gaps 6 mm and 8 mm) indicating that a 
caudo-cranial reduction of the CTV for these individuals could 
be safe. However, for the remaining 8 patients the tongue 
was mostly located cranially towards the palate. It was not 
possible to identify a relationship between the size of the air 
gap and clinical parameters such as resected volume, tumor 
size, infiltration depth, patient age or gender. 
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Conclusion: PORT for tongue cancer without intraoral stent is 
best planned with the target volume extending towards the 
palate to allow for inter-fractional movement of the tongue. 
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Purpose or Objective: Anatomical changes taking place over 
the course of radiation therapy (RT) result in a difference 
between planned and delivered dose. For pancreatic cancer, 
we investigated the robustness of clinical treatment plans by 
quantifying the dosimetric effects of changes in gas volumes, 
body contour and interfractional target displacement. In 
addition, we compared the dosimetric effect of anatomical 
changes between use of bony anatomy and use of 
intratumoral fiducial markers for patient positioning. 
 
Material and Methods: Nine pancreatic cancer patients were 
included who had intratumoral markers for daily cone-beam 
CT (CBCT)-based position verification. The clinical plans (10 
MV; 1 arc VMAT; internal CTV (iCTV) to PTV margin = 10 mm) 
were used for dose calculation. To enable fraction dose 
calculations on CBCT, the planning CT was deformably 
registered to each CBCT (13–15 CBCTs per patient); air 
volumes visible on the CBCT were copied to the deformed 
CT.  
Calculations were done for marker-based registration (as 
clinically used) and for bony anatomy-based registration. For 
both methods, doses were rigidly summed to yield the 
accumulated doses on the planning CT. For each patient, all 
DVHs were normalized to yield for the planned dose to the 
PTV: V98% = 95% (100% = 36 Gy).  
To evaluate target coverage, we defined an iCTV+5mm 
volume, i.e. the iCTV expanded with a 5 mm margin to 
account for remaining uncertainties including delineation. We 
analysed D98%, Dmean and D2% for iCTV+5mm and iCTV and 
examined DVH differences for duodenum and stomach, the 
organs at risk closest to the iCTV. 
 
Results: For the iCTV+5mm, D98% changed from mean 96.3% 
(range 95.5–97.8%) for the planned dose to 96.7% (96.4–
97.0%) for marker-based accumulated dose (Table 1).  
 
 
 
These relatively small differences indicate a limited 
dosimetric effect from changes in gas and body contour, even 
though the amount of gas visible on CBCT showed large 
variations (avg. 166 ml, SD 145 ml).  
In contrast, D98% decreased to 95.3% (85.8–97.9%) for bony 
anatomy registration, due to systematic errors inherently 
associated with bony-anatomy patient positioning. Changes 
for stomach and duodenum depended strongly on the 
direction of these errors, with large increases in D2% for 
some (error in direction of organ) and large decreases for 
others. Differences were largest for the stomach (e.g. D2% 
from 72.7% (planned) to 82.4% (bony anatomy-based 
accumulated)). For marker-based positioning, the dosimetric 
effects for stomach and duodenum were limited (<0.5 Gy in 8 
out of 9 patients). 
 
Conclusion: Photon irradiation of pancreatic tumours is 
robust to variations in body contour and gastrointestinal gas, 
with dose coverage only mildly affected by these anatomical 
changes. However, when using bony anatomy for patient 
positioning, dose coverage declines due to interfractional 
tumour position variations. Therefore, the use of fiducial 
marker-based daily position verification is essential in RT for 
pancreatic cancer. 
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Purpose or Objective: Patients undergoing prostate intensity 
modulated arc therapy (IMAT) were retrospectively 
investigated using the CBCT images acquired for setup 
purposes to determine the volumetric variability of the target 
and organs at risk and the dosimetric implications of these 
changes. 
 
Material and Methods: IMAT plans from 11 patients were 
designed to deliver 74 Gy in 37 fractions to the target. The 
CTV consisted of the prostate and seminal vesicles, while the 
PTV was the CTV plus a margin of 10 mm in all directions 
except posteriorly, where a 5 mm margin was used. For 
between 9 and 14 of the 37 fractions, the patients were 
scanned using an on-board CBCT imager to verify the setup. 
These images were retrospectively registered to the planning 
CT using an in-house registration algorithm to determine the 
transformations between the images. The calculated 
transformation vector field was used to deform the planning 
CT so that the plan could be recalculated with the original 
MU on this new adapted CT. This allowed the determination 
of the dosimetric impact of the change in anatomical 
information from the time of acquisition of the planning CT 
to immediately prior to a given treatment fraction. The 
imaged fractions were treated as though they were 
representative of the entire treatment and were weighted 
equally for dose accumulation purposes. 
 
Results: Over the course of the patients’ treatments, the 
changes in CTV volume compared to the plan were from a 
decrease of 25% up to a maximum increase of 6%. Their 
bladder volumes ranged from -10% to 10% of their respective 
volumes on the planning CT. The rectal volume decreased for 
all patients, with 5% less than the planning volume the 
smallest reduction and 34% being the largest volume 
shrinkage. 
The dosimetric impact of these anatomical changes varied for 
each structure. The minimum dose received by the CTV 
varied by less than 1% for all patients, with full coverage of 
the CTV achieved in all fractions. 
The mean dose delivered to the bladder averaged over each 
patients treatment resulted in variation of between -4% and 
17% of their respective planned mean doses. This did not 
result in a break of the dose-volume constraints (DVCs) for 
the bladder at any fraction, for any patient. 
The rectum received a higher mean dose than the planned 
value for all patients. This ranged from an increase of 7% up 
to 38%. It was found that the rectum frequently broke 
multiple DVCs, resulting in the rectum being overdosed in 
79% of the fractions examined. 
 
Conclusion: Analysis of the anatomical condition of the 
patient on the day of treatment can give an indication of how 
suitable the original plan for their treatment is. For these 
patients, although the variability in the anatomy did not 
